SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-021095
Filing Date
2024-02-27
Accepted
2024-02-27 16:05:20
Documents
14
Period of Report
2024-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-20240227.htm   iXBRL 8-K 37294
2 EX-99.1 mnkd-ex99_1.htm EX-99.1 435307
3 GRAPHIC img208524907_0.jpg GRAPHIC 8836
  Complete submission text file 0000950170-24-021095.txt   621209

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20240227.xsd EX-101.SCH 25052
15 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20240227_htm.xml XML 4733
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 24686464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)